Search Ontology:
ChEBI
felypressin
- Term ID
- CHEBI:60564
- Synonyms
-
- 1-{[(4R,7S,10S,13S,16S,19R)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13,16-dibenzyl-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl]carbonyl}-L-prolyl-L-lysylglycinamide
- 2-(L-phenylalanine)-8-L-lysinevasopressin
- felipresina
- felypressin
- felypressine
- felypressinum
- L-cysteinyl-L-phenylalanyl-L-phenylalanyl-L-glutaminyl-L-asparaginyl-L-cysteinyl-L-prolyl-L-lysylglycinamide cyclic (1-6)disulfide
- Phe(2)-Lys(8)-vasopressin
- PLV-2
- Definition
- A synthetic nonapeptide comprising cysteinyl, phenylalanyl, phenylalanyl, glutaminyl, asparaginyl, cysteinyl, prolyl, lysyl, and glycinamide residues in sequence, with a disulfide bridge joining the two cysteine residues. Its antidiuretic effects are less than those of vasopressin. It is used as a vasoconstrictor in local anaesthetic injections for dental use, and is an ingredient of preparations that have been used for treatment of pain and inflammation of the mouth.
- References
-
- CAS:56-59-7
- DrugBank:DB00093
- Drug_Central:4910
- KEGG:D04137
- Patent:GB928607
- Patent:US3232923
- Reaxys:13260124
- Ontology
- ChEBI ( EBI )
- Resources
- CTD
- is a type of
-
- has_role
-
Phenotype
Phenotype resulting from felypressin
Phenotype where environments contain felypressin
Phenotype modified by environments containing felypressin
Human Disease Model